Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin

被引:29
作者
Cassoni, P
Muccioli, G
Marrocco, I
Volante, M
Allia, E
Ghigo, E
Deghenghi, R
Papotti, M
机构
[1] Univ Turin, Dept Biomed Sci & Oncol, Turin, Italy
[2] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy
[3] Univ Turin, Dept Internal Med, Turin, Italy
[4] Europeptides, Argenteuil, France
关键词
Cortistatin; thyroid cancer; cell proliferation; inhibition; somatostatin; GH-secretagogues;
D O I
10.1007/BF03344019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cortistatin (CST-14, Pro-c[Cys-LysAsn- Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys]-Lys-NH2), a neuropeptide member of the SRIH family, binds to all 5 SRIH receptor (sst) subtypes, but also possesses a significant binding affinity to GH secretagogue receptors (GHS-R), which have been reported to mediate the antiproliferative activity of GHS on thyroid cancer cells. The effect of CST-14 on cell proliferation was studied in 3 different human thyroid carcinoma cell lines of follicular origin (N-PAP, WRO, ARO) and in one thyroid medullary carcinoma cell line (TT). CST-14 1 muM determined a significant inhibition of cell proliferation in TT, N-PAP and WRO cells and this effect was dose-dependent and more pronounced than that displayed by SRIH-14 (Ala-Gly-c[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr- Ser-Cys]-OH) treatment. To a minor extent, CST-14, but not SRIH-14, also temporary inhibited ARO cell proliferation. By immunofluorescence, sst2, sst3 and sst5 have been demonstrated in TT cells, whereas types 3 and 5 only were expressed in N-PAP and WRO cells, and no sst subtype was found in ARO cells. The presence of both GHS-R1a and 1b mRNA has been studied and demonstrated in the TT medullary carcinoma cell line, whereas follicular derived cell lines were already known to express GHS binding sites. Addition of EP-80874 (D-Mrp-c[D-Cyspyridilalanyl(3)-D-Trp-Lys-Val-Cys]-Mrp-NH2), a synthetic peptide that binds to SRIH and GHS-R, completely abolished the antiproliferative effects of CST-14 or SRIH-14 4 on sst/GHS-R positive thyroid carcinoma cell lines (WRO, N-PAP and TT). EP-80874 was also able to antagonize the inhibitory activity of CST-14 on the growth of cells (ARO) expressing GHS-R but not sst. Taken together, these data firstly demonstrate that EP-80874 has a mixed SRIH/CST antagonist activity and suggest that the oncostatic effect of CST-14 on thyroid cancer cells could be mediated by both sst and/or GHS-R. (C) 2002, Editrice Kurtis.
引用
收藏
页码:362 / 368
页数:7
相关论文
共 15 条
[1]   Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines [J].
Ain, KB ;
Taylor, KD ;
Tofiq, S ;
Venkataraman, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1857-1862
[2]   SOMATOSTATIN ANALOGS AFFECT PROLIFERATION OF HUMAN THYROID-CARCINOMA CELL-LINES IN-VITRO [J].
AIN, KB ;
TAYLOR, KD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1097-1102
[3]   Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue [J].
Cassoni, P ;
Papotti, M ;
Catapano, F ;
Ghè, C ;
Deghenghi, R ;
Ghigo, E ;
Muccioli, G .
JOURNAL OF ENDOCRINOLOGY, 2000, 165 (01) :139-146
[4]   Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland [J].
Deghenghi, R ;
Papotti, M ;
Chigo, E ;
Muccioli, G ;
Locatelli, V .
ENDOCRINE, 2001, 14 (01) :29-33
[5]   Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland [J].
Deghenghi, R ;
Papotti, M ;
Ghigo, E ;
Muccioli, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (01) :RC1-RC3
[6]   Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin [J].
deLecea, L ;
RuizLozano, P ;
Danielson, PE ;
PeelleKirley, J ;
Foye, PE ;
Frankel, WN ;
Sutcliffe, JG .
GENOMICS, 1997, 42 (03) :499-506
[7]   Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo [J].
Hoelting, T ;
Duh, QY ;
Clark, OH ;
Herfarth, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (07) :2638-2641
[8]   The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors [J].
Korbonits, M ;
Bustin, SA ;
Kojima, M ;
Jordan, S ;
Adams, EF ;
Lowe, DG ;
Kangawa, K ;
Grossman, AB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :881-887
[9]  
PAPOTTI M, 2001, IN PRESS VIRCH ARCH
[10]   [125I]Tyr10-cortistatin14 labels all five somatostatin receptors [J].
Siehler, S ;
Seuwen, K ;
Hoyer, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (05) :483-489